Naratriptan



- TRADE NAMES: Amerge (GSK); Naramig (GSK)
- INDICATIONS: Acute migraine attacks
- CLASS: 5-HT1 agonist, Serotonin receptor antagonist, Triptan
- HALF-LIFE: 6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
5-HT1 agonists, Dihydroergotamine, Duloxetine, Ergotamine, Methysergide, Metoclopramide, Oral Contraceptives, Rizatriptan, Selegiline, Sibutramine, SNRIs, SSRIs, St John's Wort, Sumatriptan, Triptans, Venlafaxine, Zolmitriptan
PREGNANCY CATEGORY: C
Contra-indicated in patients with history, symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes.
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.
Page last updated 08/02/2021
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric